Literature DB >> 16621663

Transplantation of human neural precursor cells in the 6-OHDA lesioned rats: effect of immunosuppression with cyclosporine A.

Sigrid C Schwarz1, Jan Wittlinger, Ralf Schober, Alexander Storch, Johannes Schwarz.   

Abstract

Neural precursor cells (NPC) may provide a source for restaurative therapy. We wanted to study the immunogenic potential of human NPC. We transplanted human NPCs with or without cyclosporine A (10 mg/kg) expanded in serum-free conditions into the striatum of rats unilaterally lesioned with 6-hydroxydopamine. Four months after transplantation, there was significant improvement of amphetamine-induced rotational behavior 9 non-immunosuppressed (13.1+/-4.9 pre vs 8.5+/-4.0 after grafting) but nor for 11 animals immunosuppressed with CyA (12.3+/-1.7 vs 11.3+/-2.8). The number of TH-IR cells was comparable in both groups (1,580+/-700 vs 1,274+/-295). All grafted animals only showed mild activation of astrocytes and macrophages within the graft. There was no evidence for tumor formation. Immunosuppression of rats, xenotransplanted with human NPC did not improve graft survival or function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16621663     DOI: 10.1016/j.parkreldis.2006.01.003

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  12 in total

1.  Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease.

Authors:  Rosario Sanchez-Pernaute; Hyojin Lee; Michaela Patterson; Casper Reske-Nielsen; Takahito Yoshizaki; Kai C Sonntag; Lorenz Studer; Ole Isacson
Journal:  Brain       Date:  2008-07-22       Impact factor: 13.501

Review 2.  The pharmacology of regenerative medicine.

Authors:  George J Christ; Justin M Saul; Mark E Furth; Karl-Erik Andersson
Journal:  Pharmacol Rev       Date:  2013-07-01       Impact factor: 25.468

3.  Stem cell-based therapies in Parkinson's disease: future hope or current treatment option?

Authors:  Kai Loewenbrück; Alexander Storch
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

4.  Intrastriatal transplantation of adult human neural crest-derived stem cells improves functional outcome in parkinsonian rats.

Authors:  Janine Müller; Christiana Ossig; Johannes F W Greiner; Stefan Hauser; Mareike Fauser; Darius Widera; Christian Kaltschmidt; Alexander Storch; Barbara Kaltschmidt
Journal:  Stem Cells Transl Med       Date:  2014-12-05       Impact factor: 6.940

5.  MHC mismatch results in neural progenitor cell rejection following spinal cord transplantation in a model of viral-induced demyelination.

Authors:  Jason G Weinger; Brian M Weist; Warren C Plaisted; Suzi M Klaus; Craig M Walsh; Thomas E Lane
Journal:  Stem Cells       Date:  2012-11       Impact factor: 6.277

6.  Characterization of voltage-gated potassium channels in human neural progenitor cells.

Authors:  Grit Schaarschmidt; Florian Wegner; Sigrid C Schwarz; Hartmut Schmidt; Johannes Schwarz
Journal:  PLoS One       Date:  2009-07-08       Impact factor: 3.240

7.  Cyclosporin A increases recovery after spinal cord injury but does not improve myelination by oligodendrocyte progenitor cell transplantation.

Authors:  He-Zuo Lü; Yan-Xia Wang; Jian-Sheng Zhou; Feng-Chao Wang; Jian-Guo Hu
Journal:  BMC Neurosci       Date:  2010-10-12       Impact factor: 3.288

8.  MHC mismatch inhibits neurogenesis and neuron maturation in stem cell allografts.

Authors:  Zhiguo Chen; Lori K Phillips; Elizabeth Gould; Jay Campisi; Star W Lee; Brandi K Ormerod; Monika Zwierzchoniewska; Olivia M Martinez; Theo D Palmer
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

9.  Soluble NgR fusion protein modulates the proliferation of neural progenitor cells via the Notch pathway.

Authors:  Xin Li; Huanxing Su; Qing-Ling Fu; Jiasong Guo; Daniel H S Lee; Kwok-Fai So; Wutian Wu
Journal:  Neurochem Res       Date:  2011-08-07       Impact factor: 3.996

10.  Transient but not permanent benefit of neuronal progenitor cell therapy after traumatic brain injury: potential causes and translational consequences.

Authors:  Marco Skardelly; Khaled Gaber; Swen Burdack; Franziska Scheidt; Martin U Schuhmann; Heidegard Hilbig; Jürgen Meixensberger; Johannes Boltze
Journal:  Front Cell Neurosci       Date:  2014-10-14       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.